How should ifosfamide and mesna be prepared, and what intravenous fluids (IVF) should be used for hydration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ifosfamide and Mesna Preparation and Hydration Protocol

For standard-dose ifosfamide (<2.5 g/m²/day), administer mesna at a total daily dose equal to 60% of the ifosfamide dose, given as three IV bolus doses: 15 minutes before ifosfamide, then at 4 and 8 hours after each ifosfamide dose, with concurrent aggressive hydration of at least 2 liters of IV or oral fluids per day. 1, 2

Ifosfamide Preparation

Reconstitution:

  • Add 20 mL of Sterile Water for Injection to 1 gram vial (final concentration: 50 mg/mL)
  • Add 60 mL of Sterile Water for Injection to 3 gram vial (final concentration: 50 mg/mL)
  • Shake to dissolve completely 2

Further Dilution:

  • Dilute reconstituted solution to 0.6-20 mg/mL in:
    • 0.9% Sodium Chloride (Normal Saline)
    • 5% Dextrose
    • Lactated Ringer's
    • Sterile Water for Injection 2

Stability:

  • Refrigerate after preparation
  • Use within 24 hours 2
  • For prolonged 14-day continuous infusions: 20 mg/mL concentration in normal saline remains stable at room temperature for 14 days 3

Administration:

  • Standard dose: 1.2 g/m²/day for 5 consecutive days, repeated every 3 weeks 2
  • Minimum infusion time: 30 minutes 2
  • Can be given as continuous infusion over 24 hours or longer 3, 4

Mesna Dosing Regimens

Standard IV-Only Regimen (Preferred for doses >2.0 g/m²)

Calculate total daily mesna dose = 60% of total daily ifosfamide dose 1

Timing:

  • First dose: 15 minutes before ifosfamide (20% of ifosfamide dose)
  • Second dose: 4 hours after ifosfamide (20% of ifosfamide dose)
  • Third dose: 8 hours after ifosfamide (20% of ifosfamide dose) 1

Alternative IV-Oral-Oral Regimen (For doses <2.0 g/m²)

FDA-approved regimen with equivalent safety profile 1:

  • First dose: 20% of ifosfamide dose IV at time of ifosfamide administration
  • Second dose: 40% of ifosfamide dose orally at 2 hours after ifosfamide
  • Third dose: 40% of ifosfamide dose orally at 6 hours after ifosfamide
  • Total daily mesna = 100% of ifosfamide dose

Critical caveat: If patient vomits within 2 hours of oral mesna, repeat the dose orally or give IV 1

Continuous Infusion Protocol

For continuous-infusion ifosfamide:

  • Bolus: 20% of total ifosfamide dose before starting infusion
  • Continuous infusion: 40% of ifosfamide dose, continuing 12-24 hours after ifosfamide completion 1

Intravenous Fluid Protocol

Mandatory hydration: Minimum 2 liters per day (oral or IV) 2

Acceptable IV fluids:

  • 0.9% Sodium Chloride (Normal Saline) - most commonly used
  • 5% Dextrose
  • Lactated Ringer's
  • Any combination (e.g., D5 0.45% NS, D5 0.9% NS) 2

Practical approach:

  • Start IV hydration on day 1 of ifosfamide
  • Continue aggressive hydration throughout treatment and for 12-24 hours after last mesna dose
  • Monitor urine output to ensure adequate diuresis
  • For higher doses (>2.0 g/m²/day), increase hydration volume and mesna duration 5

Important Clinical Considerations

High-dose ifosfamide (>2.5 g/m²/day):

  • Standard mesna dosing may be insufficient
  • Consider more frequent and prolonged mesna administration due to longer ifosfamide half-life 1
  • Increase both hydration volume and mesna dosage 5

Outpatient administration:

  • Selected patients without contraindications (excessive nausea/vomiting) can complete hydration after discharge 6, 4
  • Shortened 9-hour hyperhydration protocols show equivalent safety to traditional 24-hour protocols 4
  • For 14-day continuous infusions: use portable pumps with 20 mg/mL concentration without bag replacement 3

Monitoring:

  • No specific hemorrhagic cystitis monitoring protocol is established by guidelines 1
  • Clinically monitor for dysuria, frequency, hematuria
  • Daily IFO doses >2.0 g/m²/day significantly increase hemorrhagic cystitis risk 5

Common pitfall: The oral mesna regimen uses different timing (2 and 6 hours) compared to the older IV-oral regimen (2 and 8 hours). Use the FDA-approved 2 and 6 hour schedule 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.